Adverum Biotechnologies logo

Adverum Biotechnologies

ADVM | NASDAQ
Chart Builder DCF Calculator
$4.36
$0.00 (0.00%)
At close: Dec 9, 2025, 4:00 PM ET
+0.00%

Rating

Updated: Sep 21, 2026
6.8
Fundamentals Weak
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $96.26M
1D Range
4.24 4.36
52W Range
1.78 6.07

Valuation (TTM)

PE -0.51
PB -1.73
EV/EBITDA -0.79

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $8.90
Loading financial charts...

Profile

Adverum Biotechnologies, Inc. is a clinical-phase biotechnology firm primarily engaged in discovering and advancing gene therapies. The company's mission is to create innovative treatments for various...

Sector Healthcare
Industry Biotechnology
Employees 155
IPO Date Jul 31, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$5.00
Upside
+14.68%
Buy (0)
Hold (2)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.